Natixis Makes New $74,000 Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Natixis bought a new position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 57,246 shares of the biotechnology company’s stock, valued at approximately $74,000. Several other hedge funds and other institutional investors have also recently bought […]
6 Dec 14:02 · The Markets Daily